Predictors of the Development of Hyperkalemia in Patients Using Angiotensin-Converting Enzyme Inhibitors

Publisher： Karger

E-ISSN： 1421-9670|20|4|268-272

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.20, Iss.4, 2000-09, pp. : 268-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Negative Effect of Angiotensin-Converting Enzyme Inhibitors on Erythropoietin Response in CAPD Patients

By  

American Journal of Nephrology, Vol. 20, Iss. 3, 2000-06 ,pp. : 248-248

Karger

Access to resources Recommend Favorite

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 6, 2014-12 ,pp. : 573-580

Karger

Access to resources Recommend Favorite

Effects of an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitors on Burst Forming Units-Erythroid in Chronic Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 23, Iss. 5, 2003-09 ,pp. : 287-293

Karger

Access to resources Recommend Favorite

Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria

By  

Kidney and Blood Pressure Research, Vol. 42, Iss. 2, 2017-06 ,pp. : 358-368

Karger

Access to resources Recommend Favorite

Effect of Angiotensin-Converting Enzyme Inhibitors on Response to Erythropoietin Therapy in Chronic Dialysis Patients

By  

American Journal of Nephrology, Vol. 18, Iss. 6, 1998-12 ,pp. : 498-503

Karger

Access to resources Recommend Favorite